Relationship of the Chinese Medical Constitution & Syndromes in Patients With Polycystic Ovary Syndrome

June 6, 2020 updated by: Chien-Jung Lin, Tri-Service General Hospital

Study of the Relationship of the Chinese Medical Constitution & Syndromes and Quality of Life in Patients With Polycystic Ovary Syndrome

This study is a cross-sectional study. The purpose is to understand the characteristics of Chinese medicine constitutional syndrome in patients with polycystic ovary. In addition, the health-related quality of life (SF-36), mental state (stress, depression) of patients with polycystic ovary , Anxiety) and the relationship between hormone biochemical indicators and TCM constitutional syndromes, to develop a pioneering study on TCM constitution diagnosis and life guidelines for polycystic ovarian patients and future clinical adjuvant therapy.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The study conducted in the Obstetrics and Gynecology Department of the Neihu District of the Taipei Three Military General Hospital. It is expected that 200 cases of polycystic ovary will be diagnosed by specialists; "Quality of Life Questionnaire (SF-36)" evaluates the quality of life of patients; "BAI and BDI-II" evaluates patients 'anxiety and depression; "Stress Perception Scale" evaluates patients' life stress And testing the blood indexes of patients such as FSH, LH, E2, testosterone, TSH, prolactine. Observe the correlation between the quality of life, psychological state, and blood test values of polycystic ovarian patients with physical characteristics of traditional Chinese medicine.

Study Type

Observational

Enrollment (Actual)

180

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women diagnosed with Polycystic Ovary Syndrome and non Polycystic Ovary Syndrome

Description

Inclusion Criteria:

A polycystic ovarian patient was diagnosed by a specialist in obstetrics and gynecology according to the diagnostic criteria set by the Rotterdam ESHRE / ASRM-sponsored PCOS workshop group (2004) in 2003.

Exclusion Criteria:

  1. Exclude diseases similar to the clinical manifestations of polycystic ovary, such as cushing syndrome, congenital adrenal hyperplasia, thyroid dysfunction, and hyperprolactinemia.
  2. Diagnose a clear mental disorder (such as schizophrenia, severe depression) or take psychiatric drugs (anti-depression or anxiety drugs).
  3. Pregnancy, oral contraceptives, use high-dose exogenous androgens, breastfeeding.
  4. Those with a history of stroke, myocardial infarction, major trauma or surgery within the past six months.
  5. Have taken Chinese medicine in the past month.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Polycystic Ovary Syndrome
Polycystic Ovary Syndrome women
no intervention
control
non- Polycystic Ovary Syndrome women
no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
participants with PCOS and non-PCOS assessed Chinese Body Constitution & Syndromes by Body Constitution Questionnaire
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
The TCM Body Constitution Questionnaire (BCQ) was developed by Su and is a tool used to measure and study constitution deviations clinically. The questionnaire comprises 44 questions and employs a Likert 5-point scale (from 1, "Never happens," to 5, "Always happens"). The instrument consists of three subscales. The yang-xu and yin-xu constitution subscales each have 19 questions, and the stasis constitution subscale has 16 questions. The three measures share some questions. The higher the score is, the more significant the constitution deviation is. When the yang-xu constitution score is ≥ 30.5, the respondent is diagnosed as yang-xu. When the yin-xu constitution score is ≥ 29.5, the respondent is diagnosed as yin-xu. For the phlegm stasis constitution, the standard is ≥ 26.5 points. The instrument has favorable factorial validity. Cronbach's α of each subscale is 0.85-0.88, and Cronbach's αof the overall BCQ reaches 0.90.
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
work schedule (Day shift, Evening shift, Night shift, Not fixed, or Unemployed) of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply her work schedule (Day shift, Evening shift, Night shift, Not fixed, or Unemployed)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
average sleep duration of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply her average sleep duration (hours)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
habit of staying up late of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply her frequency(No, Sometimes, Often) of staying up late (sleeping after midnight)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
habit of smoking of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply her frequency of smoking (No, Sometimes, Less than a pack a day)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
habit of drinking of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply her frequency of drinking (No, Sometimes, often)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
habit of exercise of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply her frequency of exercise (No, Sometimes, often)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
dietary habit (Nonvegetarian or vegetarian) of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply her dietary habit (Nonvegetarian or vegetarian)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
dietary flavor preference (sour, bitter,sweet, spicy, salty) of participants with PCOS and non-PCOS were collected
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Participant reply yes or no about her dietary flavor preference (sour, bitter,sweet, spicy, salty)
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Anxiety of participants with PCOS and non-PCOS as assessed by Beck Anxiety Inventory
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
The Beck Anxiety Inventory (BAI) was established by Aaron T. Beck and his research team to measure the anxiety levels of adults and teenagers. It is a self-completed questionnaire with 21 items. The questions ask respondents whether they have experienced some common symptoms of anxiety in the previous week, including numbness or tingling, feeling hot, being unable to relax, and fear of the worst happening. The respondents report on a 4-point Likert scale that ranges from 0 (Not at all) to 3 (Severely - it bothered me a lot). The higher the total score is, the more severe the anxiety symptoms are. A total score of 0-7 implies the mildest anxiety, 8-15 is mild anxiety, 16-25 represents moderate anxiety, and 26-63 is severe anxiety. In the present study, the Chinese version of the BAI had a Cronbach's α of 0.95 and a split-half reliability of 0.92. The total scores were multiplied by 1.19, and the resulted integers were taken as the standard scores.
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Depression of participants with PCOS and non-PCOS as assessed by Beck Depression Inventory-second edition (BDI-II)
Time Frame: No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
The Beck Depression Inventory-second edition (BDI-II) was developed by Beck . It measures the depression levels of teenagers and adults through 21 questions. It consists of questions representative of the symptoms and attitudes of depression, such as feeling sad, losing interest, decreased appetite, and feeling tired. For each item, respondents select the option that best describes how they felt over the previous 2 weeks. Every question has anchors arranged according to severity, and the score ranges from 0 to 3 points. The higher the total score is, the more severe the depression symptoms are. A total score of 0-13 points is in the normal range, 14-19 implies mild depression, 20-28 moderate depression, and 29-63 severe depression.
No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 18, 2015

Primary Completion (Actual)

December 31, 2017

Study Completion (Actual)

December 31, 2017

Study Registration Dates

First Submitted

May 23, 2020

First Submitted That Met QC Criteria

June 6, 2020

First Posted (Actual)

June 11, 2020

Study Record Updates

Last Update Posted (Actual)

June 11, 2020

Last Update Submitted That Met QC Criteria

June 6, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polycystic Ovary Syndrome

Clinical Trials on no intervention

3
Subscribe